Dean Capital Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
Dean Capital Management's HAE Position: Q3 2026 in Review
Dean Capital Management increased its Haemonetics (HAE) stake by 0.95% in Q3 2026, buying an estimated $39.9K and bringing the position to 45,397 shares worth $4.78M. The position accounts for 1.82% of the portfolio, ranked #2.
Dean Capital Management first reported a position in HAE in Q2 2014 and has held it in 17 quarters since. 361 funds tracked by Wall St. Rank hold HAE as of Q3 2026.
- Dean Capital Management held 45,397 shares of Haemonetics worth $4.78M as of Q3 2026.
- Dean Capital Management bought 429 Haemonetics shares in Q3 2026, an estimated $39.9K.
- Haemonetics made up 1.82% of Dean Capital Management's portfolio in Q3 2026, its #2 holding.
- Dean Capital Management first reported a position in Haemonetics in Q2 2014 and has held it in 17 quarters since.
- 361 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.
Based on Dean Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.